TCL Archive In Brief: First Peer-Reviewed Comprehensive Centers Named; Sawaya To Lead Anderson Neurosurgery October 5, 1990
TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004